BioVie (BIVI) vs Kiora Pharmaceuticals (KPRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Kiora Pharmaceuticals (KPRX) has outperformed BioVie (BIVI) over the past year, losing 7.3% versus a loss of 30.3%. Over five years, KPRX leads with a -99.6% price change compared with -99.8% for BIVI. BioVie is the larger company by market cap ($11.7 million vs $11.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BIVI | KPRX |
|---|---|---|
| Share price | $1.35 | $2.51 |
| Market cap | $11.72M | $11.11M |
| 1-day change | -3.57% | -0.79% |
| YTD return | +20.69% | +28.43% |
| 1-year return | -30.35% | -7.33% |
| 5-year return | -99.76% | -99.64% |
| EPS (TTM) | $-3.05 | $-2.46 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.79 | $2.91 |
| 52-week low | $0.82 | $1.77 |
| Distance from 52-week high | -64.38% | -13.75% |
| Average volume | 4.60M | 17.13K |
| Shares outstanding | 8.68M | 4.42M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- KPRX has outperformed BIVI by 23.0 percentage points over the past year.
BIVI vs KPRX FAQ
Which is bigger, BioVie or Kiora Pharmaceuticals?
BioVie (BIVI) is larger, with a market capitalization of $11.72M compared with $11.11M for Kiora Pharmaceuticals (KPRX).
Which stock has performed better over the past year, BIVI or KPRX?
KPRX returned -7.33% over the past 12 months, compared with -30.35% for BIVI (price return, excluding dividends). Past performance does not predict future results.
Are BioVie and Kiora Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.